Comparison between Alpa Laboratories IPO and HDIL IPO.
Alpa Laboratories IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while HDIL IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Alpa Laboratories IPO is up to ₹61.07 Cr whereas the issue size of the HDIL IPO is up to ₹1,707.75 Cr. The final issue price of Alpa Laboratories IPO is ₹68.00 per share and of HDIL IPO is ₹500.00 per share.
| Alpa Laboratories IPO | HDIL IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹62.00 per share | ₹430.00 per share |
| Issue Price (Upper) | ₹68.00 per share | ₹500.00 per share |
| Issue Price (Final) | ₹68.00 per share | ₹500.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 100 shares | 14 shares |
| Fresh Issue Size | 89,80,600 shares | 3,41,55,000 shares |
| Fresh Issue Size (Amount) | up to ₹61.07 Cr | up to ₹1,707.75 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 89,80,600 shares | 3,41,55,000 shares |
| Issue Size Total (Amount) | up to ₹61.07 Cr | up to ₹1,707.75 Cr |
Alpa Laboratories IPO opens on Jul 12, 2007, while HDIL IPO opens on Jun 28, 2007. The closing date of Alpa Laboratories IPO and HDIL IPO is Jul 17, 2007, and Jul 03, 2007, respectively.
| Alpa Laboratories IPO | HDIL IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jul 12, 2007 | Jun 28, 2007 |
| Issue Close | Jul 17, 2007 | Jul 03, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Aug 06, 2007 | Jul 24, 2007 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Alpa Laboratories IPO P/E ratio is , as compared to HDIL IPO P/E ratio of .
| Alpa Laboratories IPO | HDIL IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | 43.62 | ||||
| Promoter Shareholding (Post-Issue) | 55.94 | 36.68 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹146.61 Cr. | ₹10500.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 23.57 | 74.86 |
In the Alpa Laboratories IPO Retail Individual Investors (RII) are offered 32,37,500 shares while in HDIL IPO retail investors are offered 32,37,500 shares. Qualified Institutional Buyers (QIB) are offered 46,25,000 shares in Alpa Laboratories IPO and 2,01,33,000 shares in HDIL IPO.
| Alpa Laboratories IPO | HDIL IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 46,25,000 shares | 2,01,33,000 shares |
| NII | 13,87,500 shares | 33,55,500 shares |
| RII | 32,37,500 shares | 1,00,66,500 shares |
| Employee | 2,50,000 shares | 6,00,000 shares |
| Others | ||
| Total | 95,00,000 shares | 3,41,55,000 shares |
Alpa Laboratories IPO subscribed 1.11x in total, whereas HDIL IPO subscribed 6.62x.
| Alpa Laboratories IPO | HDIL IPO | |
|---|---|---|
| QIB (times) | 0.18x | 10.13x |
| NII (times) | 1.99x | 1.78x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.14x | 1.59x |
| Employee (times) | 0.01x | 0.04x |
| Other (times) | ||
| Total (times) | 1.11x | 6.62x |
